PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)
conference contribution
posted on 2018-11-01, 00:00 authored by Mustafa Khasraw, Michael Weller, David Lorente Estelles, Kathryn Kolibaba, Chee Lee, Craig Gedye, Macarena De La Fuente, David Vicente, David Reardon, Laureen Ojalvo, Christoph Helwig, Carole Gourmelon, Morris GrovesPHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)
